Ignite Creation Date:
2024-07-17 @ 11:38 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06463327
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-17
First Post:
2024-05-08
Brief Title:
ACHIEVE2 - Safety and Preliminary Efficacy of Intravenous TCB008 in Patients With Relapse or Refractory Acute Myeloid Leukemia AML or Myelodysplastic Syndrome MDSAML
Sponsor:
TC Biopharm
Organization:
TC Biopharm
Organization Data
Organization:
TC Biopharm
Class:
INDUSTRY
Study ID:
TCB008-003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
TC Biopharm
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None